4.5 Article

Low-dose Anti-thymocyte Globulin Inhibits Human B-cell Differentiation into Antibody-Secreting Cells

Journal

ACTA DERMATO-VENEREOLOGICA
Volume 95, Issue 6, Pages 676-680

Publisher

ACTA DERMATO-VENEREOLOGICA
DOI: 10.2340/00015555-2046

Keywords

anti-thymocyte globulin; B cells; pemphigus vulgaris

Categories

Funding

  1. Deutsche Forschungsgemeinschaft [SFB650]

Ask authors/readers for more resources

Anti-thymocyte globulin (ATG) is used in the treatment of acute organ rejection. We studied in vitro the effect of low-dose ATG on B-cell activation and differentiation to antibody-secreting cells, as this may have an effect on B cell-driven autoimmune diseases, such as pemphigus vulgaris. Immunoglobulin production was analysed in the supernatants of peripheral blood mononuclear cells (PBMC) and CD19(+) B cells from healthy donors and from patients with different autoimmune diseases. B-cell proliferation, viability and differentiation were analysed using flow cytometry. Differentiation of B cells to immunoglobulin G (IgG) secreting cells was significantly reduced by ATG, but not by control unspecific IgG from non-immunized rabbits (rIgG). B-cell viability was not altered by sub-depleting concentrations of ATG. In contrast, B-cell proliferation was enhanced by ATG. When PBMC from patients with autoimmune diseases were studied, specific autoantibodies could be detected in 1 out of 10 patients. In this patient, who had pemphigus vulgaris, ATG not only decreased total IgG, but decreased also specific anti-desmoglein-3. In conclusion, these data suggest that ATG at low concentrations inhibits B-cell differentiation and function.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Allergy

Patch testing shellac in consecutive patients-Data of the Information Network of Departments of Dermatology (IVDK) 2021

Steffen Schubert, Margitta Worm, Heinrich Dickel, Nicola Wagner, Richard Brans, Claudia Schroder-Kraft, Andrea Bauer, Andre Koch, Johannes Geier

CONTACT DERMATITIS (2023)

Review Allergy

Lack of Harmonized Adherence Criteria in Allergen Immunotherapy Prevents Comparison of Dosing and Application Strategies: A Scoping Review

Caroline Beutner, Jochen Schmitt, Margitta Worm, Martin Wagenmann, Christian Albus, Timo Buhl

Summary: Allergen immunotherapy (AIT) involves gradually increasing the dose of allergen extract until immunologic tolerance is achieved. Adherence to AIT is crucial for long-term success, but measuring adherence and persistence rates has been inconsistent. The development of standardized tools and parameters for measuring adherence in AIT is necessary. Additionally, exploring methods from adherence research in other chronic diseases could help improve outcomes in AIT.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2023)

Article Dermatology

Itching in Atopic Dermatitis: Patient- and Physician-reported Outcomes in the German Atopic Dermatitis Registry TREATgermany

Elke Weisshaar, Philipp Bentz, Christian Apfelbacher, Eva Haufe, Luise Heinrich, Annice Heratizadeh, Susanne Abraham, Inken Harder, Andreas Kleinheinz, Andreas Wollenberg, Knut Schaekel, Franca Wiemers, Julia Ertner, Matthias Augustin, Julia Wildberger, Ralph von Kiedrowski, Margitta Worm, Alexander Zink, Isaak Effendy, Andrea Asmussen, Mario Pawlak, Michael Sticherling, Melanie Hilgers, Christiane Handrick, Sven Quist, Beate Schwarz, Magnus Bell, Petra Staubach-Renz, Sung-Hei Hong-Weldemann, Bernhard Homey, Jens-Joachim Bruecher, Stephan Weidinger, Thomas Werfel, Jochen Schmitt

Summary: TREATgermany is a disease registry that investigates the severity, symptoms, treatment, and quality of life in patients with moderate to severe atopic dermatitis. The results show that 97.2% of patients experienced itch, and the severity of itch is correlated with the patient's self-reported disease severity.

ACTA DERMATO-VENEREOLOGICA (2023)

Biographical-Item Allergy

Obituary: Jorg Kleine-Tebbe

Stephanie Dramburg, Susanne Lau, Paolo Matricardi, Margitta Worm, Cezmi A. Akdis, Claus Bachert, Bruce Bochner, Stephen Durham, Johannes Ring, Heimo Breiteneder, Rudolf Valenta, Claudia Traidl-Hoffman

ALLERGY (2023)

Letter Dermatology

Itching and treatments in atopic dermatitis (AD): results from the German AD registry TREATgermany

Elke Weisshaar, Philipp Bentz, Eva Haufe, Luise Heinrich, Christian Apfelbacher, Annice Heratizadeh, Susanne Abraham, Inken Harder, Andreas Kleinheinz, Andreas Wollenberg, Knut Schaekel, Franca Wiemers, Konstantin Ertner, Matthias Augustin, Julia Wildberger, Ralph von Kiedrowski, Margitta Worm, Alexander Zink, Isaak Effendy, Andrea Asmussen, Mario Pawlak, Michael Sticherling, Melanie Hilgers, Christiane Handrick, Sven Quist, Beate Schwarz, Magnus Bell, Petra Staubach-Renz, Su-Hei Hong-Weldemann, Bernhard Homey, Jens Bruecher, Stephan Weidinger, Thomas Werfel, Jochen Schmitt

BRITISH JOURNAL OF DERMATOLOGY (2023)

Review Allergy

Health-related quality of life in food and venom induced anaphylaxis and role of influencing factors

Veronika Hoefer, Matteo Martini, Sabine Doelle-Bierke, Margitta Worm, Maria Beatrice Bilo

Summary: The impact on health-related quality of life (HRQL) is crucial for patients with allergies and anaphylaxis. This narrative review focuses on HRQL in allergic patients with food and venom allergies, which are the most common triggers for severe and life-threatening reactions. The review highlights the availability of standardized assessment tools for measuring HRQL in these patients and the various factors that can influence HRQL, including sociodemographic data and external factors. The review also emphasizes the importance of considering lifestyle factors and measuring individual changes in HRQL during specific immunotherapy.

CLINICAL AND EXPERIMENTAL ALLERGY (2023)

Review Allergy

Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis

J. Bousquet, E. Melen, T. Haahtela, G. H. Koppelman, A. Togias, R. Valenta, C. A. Akdis, W. Czarlewski, M. Rothenberg, A. Valiulis, M. Wickman, M. Akdis, D. Aguilar, A. Bedbrook, C. Bindslev-Jensen, S. Bosnic-Anticevich, L. P. Boulet, C. E. Brightling, L. Brussino, E. Burte, M. Bustamante, G. W. Canonica, L. Cecchi, J. C. Celedon, C. Chaves Loureiro, E. Costa, A. A. Cruz, M. Erhola, B. Gemicioglu, W. J. Fokkens, J. Garcia-Aymerich, S. Guerra, J. Heinrich, J. C. Ivancevich, T. Keil, L. Klimek, P. Kuna, M. Kupczyk, V. Kvedariene, D. E. Larenas-Linnemann, N. Lemonnier, K. C. Lodrup Carlsen, R. Louis, M. Makela, M. Makris, M. Maurer, I. Momas, M. Morais-Almeida, J. Mullol, R. N. Naclerio, K. Nadeau, R. Nadif, M. Niedoszytko, Y. Okamoto, M. Ollert, N. G. Papadopoulos, G. Passalacqua, V. Patella, R. Pawankar, N. Pham-Thi, O. Pfaar, F. S. Regateiro, J. Ring, P. W. Rouadi, B. Samolinski, J. Sastre, M. Savoure, N. Scichilone, M. H. Shamji, A. Sheikh, V. Siroux, B. Sousa-Pinto, M. Standl, J. Sunyer, L. Taborda-Barata, S. Toppila-Salmi, M. J. Torres, I. Tsiligianni, E. Valovirta, O. Vandenplas, M. T. Ventura, S. Weiss, A. Yorgancioglu, L. Zhang, A. H. Abdul Latiff, W. Aberer, I. Agache, M. Al-Ahmad, I. Alobid, I. J. Ansotegui, S. H. Arshad, E. Asayag, C. Barbara, A. Baharudin, L. Battur, K. S. Bennoor, E. C. Berghea, K. C. Bergmann, D. Bernstein, M. Bewick, H. Blain, M. Bonini, F. Braido, R. Buhl, R. S. Bumbacea, A. Bush, M. Calderon, M. Calvo-Gil, P. Camargos, L. Caraballo, V. Cardona, W. Carr, P. Carreiro-Martins, T. Casale, A. M. Cepeda Sarabia, R. Chandrasekharan, D. Charpin, Y. Z. Chen, I. Cherrez-Ojeda, T. Chivato, E. Chkhartishvili, G. Christoff, D. K. Chu, C. Cingi, J. Correia de Sousa, C. Corrigan, A. Custovic, G. D'Amato, S. Del Giacco, F. De Blay, P. Devillier, A. Didier, M. do Ceu Teixeira, D. Dokic, H. Douagui, M. Doulaptsi, S. Durham, M. Dykewicz, T. Eiwegger, Z. A. El-Sayed, R. Emuzyte, A. Fiocchi, N. Fyhrquist, R. M. Gomez, M. Gotua, M. A. Guzman, J. Hagemann, S. Hamamah, S. Halken, D. M. G. Halpin, M. Hofmann, E. Hossny, M. Hrubisko, C. Irani, Z. Ispayeva, E. Jares, T. Jartti, E. Jassem, K. Julge, J. Just, M. Jutel, I. Kaidashev, O. Kalayci, A. F. Kalyoncu, P. Kardas, B. Kirenga, H. Kraxner, I. Kull, M. Kulus, S. La Grutta, S. Lau, L. Le Tuyet Thi, M. Levin, B. Lipworth, O. Lourenco, B. Mahboub, E. Martinez-Infante, P. Matricardi, N. Miculinic, N. Migueres, F. Mihaltan, Y. Mohammad, M. Moniuszko, S. Montefort, H. Neffen, K. Nekam, E. Nunes, D. Nyembue Tshipukane, R. O'Hehir, I. Ogulur, K. Ohta, K. Okubo, S. Ouedraogo, H. Olze, I. Pali-Schoell, O. Palomares, K. Palosuo, C. Panaitescu, P. Panzner, H. S. Park, C. Pitsios, D. Plavec, T. A. Popov, F. Puggioni, S. Quirce, M. Recto, M. S. Repka-Ramirez, C. Robalo Cordeiro, N. Roche, M. Rodriguez-Gonzalez, J. Romantowski, N. Rosario Filho, M. Rottem, H. Sagara, F. S. Serpa, Z. Sayah, S. Scheire, P. Schmid-Grendelmeier, J. C. Sisul, D. Sole, M. Soto-Martinez, M. Sova, A. Sperl, O. Spranger, R. Stelmach, C. Suppli Ulrik, M. Thomas, T. To, A. Todo-Bom, P. V. Tomazic, M. Urrutia-Pereira, M. Valentin-Rostan, E. Van Ganse, M. van Hage, T. Vasankari, P. Vichyanond, G. Viegi, D. Wallace, D. Y. Wang, S. Williams, M. Worm, P. Yiallouros, O. Yusuf, F. Zaitoun, M. Zernotti, M. Zidarn, J. Zuberbier, J. A. Fonseca, T. Zuberbier, J. M. Anto

Summary: Asthma, rhinitis, and atopic dermatitis are interrelated clinical phenotypes. The concept of one-airway-one-disease, which simplifies the links between upper and lower airway allergic diseases, needs to be reassessed based on new data.

ALLERGY (2023)

Article Allergy

Patch testing hydroperoxides of limonene and linalool in consecutive patients-Results of the IVDK 2018-2020

Steffen Schubert, Johannes Geier, Richard Brans, Annice Heratizadeh, Birger Kraenke, Axel Schnuch, Andrea Bauer, Heinrich Dickel, Timo Buhl, Dieter Vieluf, Nicola Wagner, Margitta Worm

Summary: Positive patch test reactions to Limonene hydroperoxides (Lim-OOHs) and Linalool hydroperoxides (Lin-OOHs) were frequent in consecutive patients, but most of the reactions were weak, doubtful, or irritant in nature. Patients with irritant reactions to sodium lauryl sulphate (SLS) were more likely to react to Lim-OOHs and Lin-OOHs. It is recommended to chemically monitor test preparations to reduce irritancy and interpret patch test results carefully.

CONTACT DERMATITIS (2023)

Letter Dermatology

IL-1α/β and IL-18 profiles and their impact on claudin-1, loricrin and filaggrin expression in patients with atopic dermatitis

M. Michaelidou, D. Redhu, V. Kumari, M. Babina, M. Worm

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Letter Dermatology

The Janus kinase 1 inhibitor abrocitinib for the treatment of oral lichen planus

Farzan Solimani, Alberto Mesas-Fernandez, Amrei Dilling, Alexander Nast, Franz J. Hilke, Franziska C. Ghoreschi, Margitta Worm, Kamran Ghoreschi, Katharina Meier

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Article Medicine, General & Internal

Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis

Jonathan I. Silverberg, Emma Guttman-Yassky, Diamant Thaci, Alan D. Irvine, Linda Stein Gold, Andrew Blauvelt, Eric L. Simpson, Chia-Yu Chu, Zhuqing Liu, Renata Gontijo Lima, Sreekumar G. Pillai, Julien Seneschal

Summary: Two 52-week trials showed that treatment with lebrikizumab was effective in improving skin condition and reducing itch severity in patients with moderate-to-severe atopic dermatitis. The incidence of adverse events was generally mild to moderate and did not lead to trial discontinuation.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Review Allergy

Health-Related Quality of Life and Mental Health in Drug Hypersensitivity Reactions and Drug-Induced Anaphylaxis: A Systematic Review and Meta-Analysis

Matteo Martini, Mariateresa Di Taranto, Veronika Hoefer, Margitta Worm, Maria Beatrice Bilo

Summary: This study evaluated the prevalence, severity, and risk factors of health-related quality of life (HRQoL) and mental health in patients with drug hypersensitivity reactions (DHRs), and found that these patients commonly experience depression and anxiety, and have significantly impaired HRQoL, especially in the case of drug-induced anaphylaxis.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2023)

Article Allergy

Cow's milk and hen's egg anaphylaxis: A comprehensive data analysis from the European Anaphylaxis Registry

Ewa Cichocka-Jarosz, Sabine Doelle-Bierke, Urszula Jedynak-Wasowicz, Dominique Sabouraud-Leclerc, Alice Kohli, Lars Lange, Nikolaos G. Papadopoulos, Jonathan Hourihane, Katja Nemat, Kathrin Scherer Hofmeier, Stephanie Hompes, Hagen Ott, Lucila Lopes de Oliveira, Thomas Spindler, Christian Vogelberg, Margitta Worm

Summary: A study on anaphylaxis in children found that cow's milk and hen's egg are the main triggers. Compared to hen's egg anaphylaxis, cow's milk anaphylaxis is characterized by a higher occurrence of respiratory symptoms and a lower occurrence of cardiovascular symptoms. The clinical profiles and treatment approaches differ between the two triggers.

CLINICAL AND TRANSLATIONAL ALLERGY (2023)

Article Allergy

Vegan diets from an allergy point of view-Position paper of the DGAKI work- ing group on food allergy

I. Reese, C. Schaefer, B. Ballmer-Weber, K. Beyer, S. Doelle-Bierke, S. van Dullemen, U. Jappe, S. Mueller, S. Schnadt, R. Treudler, M. Worm

Summary: Vegan diets are receiving a lot of attention, but the risks associated with avoiding animal-based foods are not well understood. Understanding these risks from the perspective of food allergies requires the expertise of a nutritionist/dietitian. This paper discusses the benefits and challenges of a plant-based diet, as well as the potential allergic reactions to milk alternatives and other substitute products.

ALLERGOLOGIE (2023)

Article Allergy

Limited Reimbursement and Underuse of Digital Healthcare Concepts Are Major Barriers to Clinical Allergological Care in Germany

Anna Katharina Schober, Moritz Maximilian Hollstein, Regina Treudler, Sven Becker, Jelena Epping, Eckard Hamelmann, Christian Taube, Martin Wagenmann, Bettina Wedi, Margitta Worm, Alexander Zink, Timo Buhl, Thomas Werfel, Stephan Traidl

Summary: This study aims to identify and analyze potential barriers to clinical allergological care in Germany. The results showed that reimbursement and the use of digital healthcare concepts are major barriers in allergological care. There is an urgent need for researchers and policymakers to investigate and support the improvement of allergology departments in Germany.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2023)

No Data Available